Rural Health
News by Topic: Pharmacy and prescription drugs
Apr 15, 2025 - Notice of final rule from the Centers for Medicare & Medicaid Services (CMS) revising the Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), Medicare cost plan, and Programs of All-Inclusive Care for the Elderly (PACE) regulations to implement changes related to prescription drug coverage, the Medicare Prescription Payment Plan, dual eligible special needs plans (D-SNPs), Part C and Part D Star Ratings, and other programmatic areas, including the Medicare Drug Price Negotiation Program. This final rule also codifies existing sub-regulatory guidance in the Part C and Part D programs. These regulations are effective June 3, 2025.
Source: Federal Register
CMS: Agency Information Collection Activities; Proposals, Submissions, and Approvals
Federal Register
Apr 1, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on an information collection Medicare Transaction Facilitator (MTF) for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA). The MTF will collect information from manufacturers of drugs covered under Medicare Part D selected will be used for negotiation under the Inflation Reduction Act for the initial price applicability years 2026 and 2027 and the dispensing entities that dispense the selected drugs to MFP-eligible individuals. Comments are due by May 1, 2025.
Source: Federal Register
DEA: Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Federal Register
Mar 24, 2025 - Notice of final rule from the Drug Enforcement Administration and U.S. Department of Health and Human Services (HHS) further delaying the January 17, 2025, final rules titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients." These final rules will now be effective December 31, 2025.
Source: Federal Register